cached image

Philip Scheltens, MD PhD

Affiliations: 
Alzheimer Center VU University Medical Center, Amsterdam, Netherlands 
Area:
dementia, MRI, CSF, PET, http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=111
Website:
https://www.knaw.nl/nl/leden/leden/11669
Google:
"Philip Scheltens"
Bio:

http://www.alzheimercentrum.nl/
http://f1000.com/thefaculty/member/7399908664712993

http://www.quintiles.com/information-library/experts/philip-scheltens-md/

http://vas-cog.org/Bio-scheltens.html

http://www.neurodegenerationresearch.eu/about/biography/?tx_ttnews[tt_news]=16&cHash=f3b68090e92a5b3ff3346913b0bf43e7

Mean distance: 16.41 (cluster 44)
 
SNBCP
Cross-listing: Alzheimer's Tree

Parents

Sign in to add mentor
Johan Carel Koetsier grad student 1993 VU Amsterdam
Jaap Valk grad student 1993 VU Amsterdam
 (MR imaging in Alzheimer's disease)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ossenkoppele R, Reimand J, Smith R, et al. (2021) Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers. Embo Molecular Medicine. e14398
Ulugut H, Stek S, Wagemans LEE, et al. (2021) The natural history of primary progressive aphasia: beyond aphasia. Journal of Neurology
Wolters EE, Papma JM, Verfaillie SCJ, et al. (2021) [18F]Flortaucipir PET Across Various Mutations in Presymptomatic and Symptomatic Carriers. Neurology
Florentinus-Mefailoski A, Bowden P, Scheltens P, et al. (2021) The plasma peptides of Alzheimer's disease. Clinical Proteomics. 18: 17
Groot C, Risacher SL, Chen JQA, et al. (2021) Differential trajectories of hypometabolism across cognitively-defined Alzheimer's disease subgroups. Neuroimage. Clinical. 31: 102725
Hung C, Tuck E, Stubbs V, et al. (2021) SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network. Cell Reports. 35: 109259
de Rojas I, Moreno-Grau S, Tesi N, et al. (2021) Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nature Communications. 12: 3417
Prins ND, Harrison JE, Chu HM, et al. (2021) A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease. Alzheimer's Research & Therapy. 13: 106
Fieldhouse JLP, Gossink FT, Feenstra TC, et al. (2021) Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at Onset. Journal of Alzheimer's Disease : Jad
Tuncel H, Boellaard R, Coomans EM, et al. (2021) Kinetics and 28-day test-retest repeatability and reproducibility of [C]UCB-J PET brain imaging. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 41: 1338-1350
See more...